AEK-9519618-2/10002/1

Abbvie Biotechnology Gmbh — FEI 3011277200

Refusal Details

Date
March 9, 2026
Country
Germany
Product Category
Drugs and Biologics
Product Code
58SDY14 ADALIMUMAB
Charges
75